These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 30105813

  • 41. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
    Liu Q, Liang M, Liu T, Vuitton L, Zheng S, Gao X, Lu M, Li X, Sheyhidin I, Lu X.
    Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
    [Abstract] [Full Text] [Related]

  • 42. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
    Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T, Liu R, Fan Q, Zhu K, Li J, Zhan Y, Ying G, Ba Y.
    Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
    [Abstract] [Full Text] [Related]

  • 43. miR‑135a‑5p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancer.
    Diao H, Xu X, Zhao B, Yang G.
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036386
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X, Tan F, Cao X, Cao Z, Li B, Shen Z, Tian Y.
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan 02; 52(1):9-17. PubMed ID: 31867609
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
    Chang H, Xu Q, Li J, Li M, Zhang Z, Ma H, Yang X.
    Cell Death Dis; 2021 Jul 21; 12(8):725. PubMed ID: 34290225
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Downregulation of miR-181b-5p Inhibits the Viability, Migration, and Glycolysis of Gallbladder Cancer by Upregulating PDHX Under Hypoxia.
    Qin Y, Zheng Y, Huang C, Li Y, Gu M, Wu Q.
    Front Oncol; 2021 Jul 21; 11():683725. PubMed ID: 34485121
    [Abstract] [Full Text] [Related]

  • 53. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
    Wong CC, Au SL, Tse AP, Xu IM, Lai RK, Chiu DK, Wei LL, Fan DN, Tsang FH, Lo RC, Wong CM, Ng IO.
    PLoS One; 2014 Jul 21; 9(12):e115036. PubMed ID: 25541689
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
    Zhang M, Gong W, Zuo B, Chu B, Tang Z, Zhang Y, Yang Y, Zhou D, Weng M, Qin Y, Ma M, Jiang A, Ma F, Quan Z.
    Oncotarget; 2016 Nov 29; 7(48):78640-78652. PubMed ID: 27769047
    [Abstract] [Full Text] [Related]

  • 59. MicroRNA-197 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by targeting insulin-like growth factor-binding protein 3.
    Tong L, Cheng J, Zuo H, Li J.
    Adv Clin Exp Med; 2021 Jul 29; 30(7):661-672. PubMed ID: 34118139
    [Abstract] [Full Text] [Related]

  • 60. MicroRNA aberrations: An emerging field for gallbladder cancer management.
    Chandra V, Kim JJ, Mittal B, Rai R.
    World J Gastroenterol; 2016 Feb 07; 22(5):1787-99. PubMed ID: 26855538
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.